CVS will add these weight-loss options to drug plans

CVS Health will reinstate coverage of Eli Lilly’s weight-loss injectable Zepbound and begin coverage of the anti-obesity pill Foundayo.

​ CVS Health will reinstate coverage of Eli Lilly’s weight-loss injectable Zepbound and begin coverage of the anti-obesity pill Foundayo. USA TODAY – Breaking News and Latest News Today Read More